PGRN knockdown was proposed as a potential cancer therapeutic to sensitize the cells to conventional anti-cancer therapies, whereas on the other side of the spectrum, the exogenous supplementation of PGRN was suggested as a therapy for Frontotemporal Dementia28–31. Here, GRN is linked to cancer.